| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.092 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.092 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.088 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |